Innovative care

We shape science into meaningful solutions that help people live longer, better lives.

Why it matters

When we offer new sustainable solutions to address unmet patient needs, we help improve health outcomes for more people and communities globally.

Our priorities

Innovating to improve patient lives

By generating clinical evidence, investing in R&D, pursuing partnerships and leveraging artificial intelligence, we strive to meet evolving patient needs with new health care solutions.

Ensuring quality, health and safety

Our highest priority is to ensure our products are safe and reliable. Quality is embedded across all our development processes.

Advancing health access and equity

We leverage health economics, clinical outcomes and real-world data to grow the reach of our products and help lessen inequities in health care.

2023 highlights

37M+

patients served

$1.4B

annual R&D spend¹

active clinical trials

Zero

findings resulting in action following more than 415 external audit days

¹ Represents GAAP R&D expense per Annual Report on Form 10-K.

Stories of impact

FARAPULSE PFA system against a white background.

INNOVATION

Proven safety, efficacy and efficiency profile of the FARAPULSE^TM PFA System helps minimize risks of thermal ablation procedures

The FDA-approved FARAPULSE Pulsed Field Ablation (PFA) System brings a unique new alternative to standard-of-care thermal ablation treatment. Clinical data and real-world usage demonstrate the system is as effective in treating atrial fibrillation as thermal options and results in fewer unwanted side effects. With the FARAPULSE PFA System, patients experience statistically shorter ablation times and physicians have a quick learning curve.

Learn more about FARAPULSE

Three health care providers wearing protective gear stand in a line looking in the same direction.

ACCESS

On-demand digital platforms empower and support health care providers

In 2023, over 59,000 health care professionals in more than 145 countries accessed our EDUCARE platform. This on-demand platform and our ExpertLink remote connectivity solutions offer learning tools and videos, remote preceptorships, proctorships, case support and equipment assistance so providers can stay connected to our clinical and technical experts as they deliver care to patients.

WATCHMAN implant against a white background.

INNOVATION

New stroke reduction technology advances procedural performance and safety

The WATCHMAN Left Atrial Appendage Closure Device is now the most implanted FDA-approved implant, proven to reduce stroke risk in people with atrial fibrillation not caused by a heart valve problem. To date, more than 500,000 WATCHMAN procedures have been successfully completed around the world.

Learn more about the WATCHMAN device

Illustration of three brown-skinned people, one of whom is wearing a stethoscope, helping each other up steps.

ACCESS

MedStar Harbor Hospital creates action plan with Close the Gap, improving to #2 for statewide disparity gap measure

Close the Gap (CTG), a Boston Scientific initiative, collaborates with providers and administrators who want to make an impact around health equity. Through the Heart and Vascular Health Equity Level-up Program, CTG uncovers care disparities and helps build action plans that increase access to needed specialty care and interventions.

Read the case study about MedStar Health in Baltimore

A woman wearing protective goggles and a hair covering looks into a microscope.

Our commitment to quality

Our Best⁴ quality strategy yields 97% effectiveness in corrective and preventative actions (CAPA) metrics and 99% on-time CAPA approvals.

Learn about our approach to quality

My account